Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,913.00    -25.00 (-1.29%)
Bid:
1,917.00
Ask:
1,918.00
Spread: 1.00 (0.052%)
Market Cap: £76.72b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

London stocks flat as investors assess mixed corporate earnings
30 Jul 2025

London stocks flat as investors assess mixed corporate earnings

FTSE 100 flat, FTSE 250 down 0.08% *

London close: Stocks mixed on robust US data, earnings flurry
30 Jul 2025

London close: Stocks mixed on robust US data, earnings flurry

(Sharecast News) - London equities ended Wednesday narrowly mixed as investors weighed stronger-than-expected US economic data against a wave of corpo...

LONDON MARKET CLOSE: FTSE 100 ends flat ahead of likely Fed rate hold
30 Jul 2025

LONDON MARKET CLOSE: FTSE 100 ends flat ahead of likely Fed rate hold

(Alliance News) - The FTSE 100 struggled for direction on Wednesday, despite progress elsewhere, as investors digested another earnings deluge and loo...

GSK expects sales, profit toward top of 2025 forecasts despite tariff, pipeline pressures
30 Jul 2025

GSK expects sales, profit toward top of 2025 forecasts despite tariff, pipeline pressures

Specialty medicines and other divisions show double-digit growth *

LONDON MARKET MIDDAY: Earnings weigh on FTSE 100 but peers climb
30 Jul 2025

LONDON MARKET MIDDAY: Earnings weigh on FTSE 100 but peers climb

(Alliance News) - The FTSE 100 went into the afternoon lower on Wednesday, though blue-chip peers in Europe were on the up and stocks in New York are ...

GSK in talks with Trump administration on U.S. drug pricing, CEO says
30 Jul 2025

GSK in talks with Trump administration on U.S. drug pricing, CEO says

LONDON, July 30 (Reuters) - British drugmaker GSK said on Wednesday it is in talks with the Trump administration about ways to lower U.S. drug costs...

GSK eyes top-end annual results as second quarter beats expectations
30 Jul 2025

GSK eyes top-end annual results as second quarter beats expectations

(Alliance News) - GSK said it expects annual sales growth at the top end of its outlook range, after "another quarter of excellent performance" saw re...

LONDON BRIEFING: GSK eyes profit at top end of range; BAE backs guide
30 Jul 2025

LONDON BRIEFING: GSK eyes profit at top end of range; BAE backs guide

(Alliance News) - GSK predicted an annual outturn at the top end of guidance, BAE Systems maintained its outlook, while Aston Martin softened its prof...